Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Advances in PET imaging of cancer
J Schwenck, D Sonanini, JM Cotton… - Nature Reviews …, 2023 - nature.com
Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …
technology, imaging probe and contrast development, and data quality, as well as machine …
Nanobodies: next generation of cancer diagnostics and therapeutics
The development of targeted medicine has greatly expanded treatment options and spurred
new research avenues in cancer therapeutics, with monoclonal antibodies (mAbs) emerging …
new research avenues in cancer therapeutics, with monoclonal antibodies (mAbs) emerging …
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
F Galli, JV Aguilera, B Palermo, SN Markovic… - Journal of experimental …, 2020 - Springer
Tumor-infiltrating immune cells play a key role against cancer. However, malignant cells are
able to evade the immune response and establish a very complex balance in which different …
able to evade the immune response and establish a very complex balance in which different …
Tumor-associated macrophages: from basic research to clinical application
L Yang, Y Zhang - Journal of hematology & oncology, 2017 - Springer
The fact that various immune cells, including macrophages, can be found in tumor tissues
has long been known. With the introduction of concept that macrophages differentiate into a …
has long been known. With the introduction of concept that macrophages differentiate into a …
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
As an essential innate immune population for maintaining body homeostasis and warding
off foreign pathogens, macrophages display high plasticity and perform diverse supportive …
off foreign pathogens, macrophages display high plasticity and perform diverse supportive …
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Monoclonal antibodies have revolutionized cancer therapy. However, delivery to tumor cells
in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal …
in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal …
Plasticity of myeloid-derived suppressor cells in cancer
E Tcyganov, J Mastio, E Chen, DI Gabrilovich - Current opinion in …, 2018 - Elsevier
Highlights•Myeloid-derived suppressor cells (MDSC) are critically important for regulation of
immune responses in cancer.•MDSC have distinct features separating them from neutrophils …
immune responses in cancer.•MDSC have distinct features separating them from neutrophils …
Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and …
Hypoxia promotes not only the invasiveness of tumor cells, but also chemoresistance in
cancer. Tumor associated macrophages (TAMs) residing at the site of hypoxic region of …
cancer. Tumor associated macrophages (TAMs) residing at the site of hypoxic region of …
Nanobodies as therapeutics: big opportunities for small antibodies
S Steeland, RE Vandenbroucke, C Libert - Drug discovery today, 2016 - Elsevier
Highlights•Nanobodies (Nbs) are camelid-derived single-domain antibodies.•Nbs have
powerful binding and inhibitory capacity with great therapeutic potential.•Nbs are used in …
powerful binding and inhibitory capacity with great therapeutic potential.•Nbs are used in …
Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo
Breast cancer is associated with the second highest cancer-associated deaths worldwide.
Therefore, understanding the key events that determine breast cancer progression …
Therefore, understanding the key events that determine breast cancer progression …